Total Funding
26
56
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
52696
Io Therapeutics is a biotechnology company developing a series of retinoid and rexinoid compounds.
- Martin Sanders: Founder, Chairman, and Chief Executive Officer
Rosh Chandraratna: Co-Founder, President & CSO
About the Company
Io Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, operating privately. Its primary objective involves the exploration and advancement of therapeutic compounds directed at nuclear receptors to address various medical conditions such as cancer, neurodegenerative disorders, and autoimmune diseases.
Women Founded
